Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Cancer Research Technology

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 7
Average round size
info
The average size of a deal this fund participated in
$23M
Portfolio companies 7
Rounds per year 0.32
Lead investments 1
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Therapeutics
  • Health Care
  • Medical
  • Life Science

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aligo Innovation Canada, Montréal, Quebec
Alta Bioequities -
Fnaim -
Hamashin Lease Hamamatsu, Japan, Shizuoka Prefecture
ILJIN Life Science -
indaa.com.cn Beijing, Beijing, China
McGraw Hill Financial New York, New York, United States
Monash Private Capital Australia, New South Wales, Sydney
New Capital Partners Alabama, Birmingham, United States
PH Investment China, Shanghai
Promon International -
Purple Bull Startups Beijing, Beijing, China
Shenzhen Qianhai Ruize Capital Management China, Fujian, Shanzhen
Slome Capital -
TBF Capital Group, LLC Deerfield, Illinois, United States
Tecum Capital Partners Pennsylvania, United States, Wexford
Tianjin JXJ Technologies Beijing, Beijing, China
Tokuyama Japan, Tokyo
Trigyn Technologies -
Trinity Investment Corporation -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Myricx Pharma

Biotechnology
Life Science
$123M08 Jul 2024 United Kingdom, England, United Kingdom

Infinitopes

Biotechnology
$17M30 Apr 2024 Oxford, Oxfordshire, United Kingdom

Neobe Therapeutics

$2M29 Feb 2024 London, England, United Kingdom

NK:IO

Biotechnology
Life Science
Manufacturing
Therapeutics
$1M25 Jul 2023 -

BioCaptiva

Health Care
Medical
Medical Device
$2M01 Jun 2022 City of Edinburgh, Scotland, United Kingdom

Achilles Therapeutics

Biotechnology
Health Care
Therapeutics
Wellness
$18M28 Sep 2016 United Kingdom, England

Biotechnology
Health Care
Health Diagnostics
Therapeutics
16 Sep 2016 London, England, United Kingdom

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Cancer Research Technology?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 7
Average round size 23M
Rounds per year 0.32
Peak activity year 2024
Lead investments 1
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Myricx Pharma

Biotechnology
Life Science
$123M08 Jul 2024 United Kingdom, England, United Kingdom

Infinitopes

Biotechnology
$17M30 Apr 2024 Oxford, Oxfordshire, United Kingdom

Neobe Therapeutics

$2M29 Feb 2024 London, England, United Kingdom

NK:IO

Biotechnology
Life Science
Manufacturing
Therapeutics
$1M25 Jul 2023 -

BioCaptiva

Health Care
Medical
Medical Device
$2M01 Jun 2022 City of Edinburgh, Scotland, United Kingdom

Achilles Therapeutics

Biotechnology
Health Care
Therapeutics
Wellness
$18M28 Sep 2016 United Kingdom, England

Biotechnology
Health Care
Health Diagnostics
Therapeutics
16 Sep 2016 London, England, United Kingdom
Crunchbase icon

Content report

The following text will be sent to our editors: